Are there risks in percutaneous interventional treatment for lung cancer? You need to bear a certain degree of risk

Lung cancer patients need to bear a certain degree of risk when undergoing invasive treatment such as percutaneous interventional therapy, such as complications such as pneumothorax and bleeding, but the probability is not high.

The occurrence of lung cancer has brought serious harm to the patient's health. So, are there risks in percutaneous interventional treatment of lung cancer? Let's find out.
The risks of percutaneous interventional treatment for lung cancer patients are relatively small and generally do not induce serious accidents. The reason is that percutaneous interventional treatment is only a minimally invasive surgery, and the puncture instrument used is only a small puncture needle, so the complications are relatively small.
However, any invasive surgery may bring some risks of complications, so percutaneous interventional treatment also has certain risks, and the most common complications of this treatment are often pneumothorax and bleeding. However, even if these complications occur, as long as the patient receives timely treatment, it will generally not induce the occurrence of more obvious adverse symptoms. Other complications are usually minimal, such as chest bleeding pain and coughing, mild hemoptysis, etc., which generally do not cause serious problems.
To sum up, percutaneous interventional treatment is a relatively safe invasive surgery. Although it may cause some complications, it is still relatively safe.